The ICAM3 gene helps immune cells recognize, attach to, and communicate with one another, especially when the body is starting an immune response. If it does not work properly, those early immune cell interactions may be less efficient. This gene plays an important role in how white blood cells signal and move through the immune system. Most variants in the ICAM3 gene are not known to cause a common inherited condition on their own.
What is a gene?
Genes are stretches of DNA that provide instructions your cells use to make molecules or regulate activities in the body. Some genes carry the code for proteins, which are the working parts of cells. Others mainly control when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ICAM3Gene function
What if the gene works
The ICAM3 gene helps immune cells stick to each other and exchange signals. This supports white blood cell movement and the early steps of immune responses.
Risk
What if the gene does not work
Changes in the ICAM3 gene can make immune cells less able to stick together and send signals to each other. Milder variants may partly reduce this surface protein’s activity, while more severe variants can greatly disrupt cell to cell communication.
Treatment
What does that mean for your treatment
No ICAM3-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the ICAM3 gene.
Gene function
What if the gene works
White blood cells need smooth, timely contact with each other to launch a measured immune response. The ICAM3 gene supports this by placing a gripping protein on the cell surface, which helps explain how white blood cells stick together during an immune response and share signals.
The protein made from the ICAM3 gene sits on white blood cells and works as a surface handhold. It helps nearby immune cells attach for the short time needed to start working together.
This protein helps T cells make early contact with dendritic cells, which show the immune system pieces of germs. These first meetings support the opening steps of an immune response.
By keeping cells close for a short time, the ICAM3 gene supports signal sharing at the cell surface. This helps immune cells coordinate their actions in a more orderly way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Research on how ICAM3 gene variants affect protein function shows that some changes distort the protein’s outer binding region, while others reduce folding, sugar attachments, or movement to the cell surface. More disruptive variants can leave little or no usable ICAM-3 protein, and milder variants may only partly weaken binding or stability inside the cell.
How variants are linked to conditions
ICAM3 does not yet have a broadly confirmed link to a specific health condition, and information about ICAM3 gene variants and health conditions is still evolving. If you have a confirmed variant in the ICAM3 gene, your doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ICAM3 gene. If a test result mentions ICAM3, its meaning usually depends on the exact genetic change and the wider clinical picture.
Inheritance of ICAM3 variants
There is not yet a broadly confirmed disease specific inheritance pattern for ICAM3 gene variants, and this may become clearer as research develops. For people looking into ICAM3 gene inheritance, it helps to know that the ICAM3 gene is located on chromosome 19, which is an autosome. That means you inherit one copy of the ICAM3 gene from your mother and one copy from your father.
What does my ICAM3 result mean for my family?
There is not yet a broadly confirmed inherited condition linked to the ICAM3 gene in the way seen for some other genes. If you have a specific ICAM3 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help explain it in the context of your family history and the exact result.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the ICAM3 gene usually uses a blood sample or cheek swab. In practice, ICAM3 genetic testing reads the gene's DNA code to look for changes and may be done on its own or as part of a larger panel. Results can show a harmless variant, a variant linked to health, or an uncertain finding.
When should I consider getting a genetic test?
There isn't yet a broadly established, ICAM3-specific clinical reason for testing. Decisions about genetic testing are usually based on your overall health picture and family history, discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies based on the condition and the specific type of variant. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small DNA differences can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may help one person more than another or cause more side effects in someone else. This kind of variation is common and is one reason medication response can differ from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation affects a person’s response to medicines. By looking at connections between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medications, genes influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the ICAM3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work, so any concerns about your health, treatment, or side effects are best discussed with your doctor.
History
In the early 1990s, researchers identified the ICAM3 gene while sorting out a growing family of immune cell surface proteins called intercellular adhesion molecules. The protein it encodes was also recognized as CD50, a naming system widely used in immunology at the time. Soon after its discovery, the gene was mapped to chromosome 19, alongside several related ICAM genes, which helped place it within a broader biological family. From these first observations, research expanded steadily. Studies in the years that followed clarified ICAM3’s role in how white blood cells interact and also brought interest because it could bind to certain viruses in laboratory research. This early work helped establish ICAM3 as a well-characterized member of the ICAM family.